Background and Objectives: Surgical trials pose many methodological challenges often not present in trials of medical interventions. If not properly accounted for, these challenges may introduce significant biases and threaten the validity of the results. Methods: We systematically reviewed the significance of randomized controlled trials in the evaluation of surgical interventions, discussed the methodological challenges encountered in designing and conducting randomized controlled trials of surgical treatments, and proposed possible solutions to overcome these challenges. Conclusions: Many barriers and issues of surgical trials affecting internal validity can be overcome with proper methodology, and in most cases these issues do not restrict their conduct. Researchers should consider their research question carefully and design a surgical trial that contains features appropriate for the question. In doing so, they must ensure that the trial is valid, feasible, and affordable-a difficult feat, but one well worth the challenge.
R
andomized controlled trials (RCTs) are the most rigorous method of determining whether a cause and effect relationship exists between treatment and outcome. Most surgical research takes the form of retrospective case series, often with a small number of patients.
1,2 Furthermore, surgical treatments are half as likely to be based on RCT evidence than are medical therapies. 3, 4 If RCTs are difficult to conduct rigorously in an area, the methodology is more likely to be faulty, and the results may then be misleading.
Surgical trials pose many methodological challenges often not present in trials of medical interventions. If not properly accounted for, these challenges may introduce significant biases and threaten the validity of the results. The objectives of this article are to review the significance of RCTs in the evaluation of surgical interventions, discuss some of the methodological challenges encountered in designing and conducting RCTs of surgical treatments, and propose possible solutions to overcome these challenges.
DESIGN OF SURGICAL TRIALS
A well-designed RCT has high internal validity and acceptable external validity (generalizability); whereas, the external validity is useful only if the internal validity of a study is maintained. Randomization offers the best method for balancing known and unknown confounding factors between treatment groups. Certain other measures, such as concealment of random allocation and blinding of individuals to the type of intervention, guard against additional bias. Consequently, if a treatment effect is observed, there will be more confidence in concluding that one intervention is better than the other.
There is debate about the feasibility of RCTs for surgical interventions 5 and the superiority of RCTs over non-RCTs or observational designs. 6 In reality, experimental and observational studies contribute complementary evidence; it is the research question that dictates the appropriate study design. Solomon et al 7 performed a systematic review of treatment evaluation questions and concluded that only 40% of treatment questions involving surgical procedures could have been evaluated by an RCT. It is important to recognize the value of evidence from non-RCTs evaluating surgical interventions when the conduct of RCTs is impractical or unethical. However, even in these situations, conclusions drawn from observational studies must be interpreted with caution. Although nonRCTs or observational designs lack the rigor of randomization to control for selection bias, other principles of high quality methodology such as blinding, intention-to-treat analysis, and complete follow-up applied for the design of an RCT should be adopted to improve the quality of observational studies.
METHODOLOGICAL CHALLENGES OF SURGICAL TRIALS AND POTENTIAL SOLUTIONS
The application of evidence-based care in the practice of surgery has improved in the past decade (ie, colorectal surgery and arthroplasty surgery), 8, 9 but surgical treatments are still less likely than medical therapies to be based on well-designed RCTs. The findings from small, underpowered, and poorly designed surgical RCTs may be overvalued because their design provides them with unwarranted credibility. 10 Moreover, rather than performing a critical appraisal of the available literature, clinicians' decisions may be influenced by the fact that an RCT design was used, and erroneous conclusions may guide clinical practice. A well-designed RCT guards against systematic and random errors. We will provide an overview of methodological features of an RCT (Box 1) and provide potential solutions to some of the issues that pose challenges in the evaluation of surgical interventions. The definitions of the methodological terms are provided in the glossary for the interested readers.
Methods to Minimize Systematic Error
Systematic error (ie, bias) is a reproducible inaccuracy that deviates the results of a study from the truth. It is usually impossible to remedy bias once it has occurred because not only is the extent unknown, the direction is usually unknown as well. For example, consider the misclassification of the outcome variable, ie, postoperative complication or quality of life (QOL). When the bias occurs equally for the 2 intervention groups, the estimate is biased toward the null value; when the differential misclassification occurs (eg, the outcome is assessed in an unblinded fashion), the bias can be in either direction, with any extent. 11 Bias may completely distort the truth if the differences between interventions are of small or moderate size. 12 Therefore, it is essential to guard against systematic or differential errors at the stage of design as well as conduct of a surgical trial.
Randomization
The purpose of randomization is to create groups of participants who have similar known and unknown prognostic factors at the start of a trial so that any differences at the completion of the trial are attributable to the intervention under investigation. A true randomization process eliminates selection bias.
For example, when a surgeon has control over what type of surgical intervention a patient will receive, she/he may, intentionally or unintentionally, assign patients with favorable characteristics to the experimental procedure. This selective assignment would introduce bias into the study because patients with favorable characteristics (such as younger age) are likely to achieve better outcomes irrespective of the intervention. As in clinical trials, randomization should be performed as close as possible to when the intervention is performed. Thus, patients can give informed consent preoperatively, but randomization occurs intraoperatively once there is certainty that both procedures can be performed. The method of randomization should always be reported because some "RCTs" allocate participants to groups in ways that are not truly random. For example, allocation by date of birth, day of the week, medical record number, or the order participants are included in the study (alternation) is called quasi-random allocation. Although these methods might seem to generate comparable groups, they cannot provide concealment of allocation which, as we will discuss in the next section, introduces a substantial risk of bias.
Random allocation of surgical patients to different surgical interventions is not always possible or practical, due to ethical constraints (sham/placebo surgery, when its' use is not ethically justified), 13 rare conditions (primary malignant bone and soft tissue tumors 5 or Hirschsprung disease 14 ) , or impractical situations (constant technical modifications to the innovative procedures as they evolve 15 ). The alternative to sham/placebo surgery is to have nonoperative treatment. Testing a surgical procedure against "nothing" is possible and ethical although it poses methodological challenges such as blinding.
Surgical researchers must differentiate these situations and incorporate other strategies to control for confounders when randomization is not possible or not necessary. The main limitation researchers must address when designing a nonrandomized study, ie, in the case of a rare disease, is the potential for differences between the 2 groups in prognostic factors. In the stage of study design, researchers can restrict the study population to patients with certain characteristics or match the study groups for one or more prognostic factors to reduce this limitation. In the stage of data analysis, researchers should apply appropriate statistical methods such as propensity score analysis and multivariable modeling to take into account the effect of these differences. Note that the use of these methods should be justified, predefined, specified and taken into account in a power calculation a priori at the stage of study design. Even then, the conclusions drawn from these studies will be less robust than conclusions generated from an RCT because one cannot eliminate the effect of all known confounders and there is no way of incorporating the effect of potential unknown confounders.
Concealment of Allocation
Allocation concealment is different from the method of randomization. Regardless of the method of randomization, the risk of bias is great when the allocation process is not concealed because investigators may (consciously or unconsciously) choose not to enroll potentially eligible patients into the trial if they do not want them to receive the allocated intervention. Thus, the main advantage of randomization is lost in trials that do not conceal allocation.
It is possible to conceal the randomization sequence in every RCT. The optimal method is to have the randomization process independently administered using, for example, a 24-hour telephone randomization line, a web-based randomization service, a hospital pharmacy, or a central office. Many trials randomize participants using envelopes containing the group allocation. While this method theoretically provides concealed allocation, it is highly susceptible to corruption if investigators open multiple envelopes, or are able to determine the group allocation without opening the envelope. The use of envelopes for the concealment of allocation should be avoided. To minimize the likelihood of abuse, if envelopes are used, they should be (a) opaque, sealed, and serially numbered; (b) opened sequentially and only after the participant's name and other details are written on the envelope; and (c) kept in a locked and secure place. 16 Most other forms of allocation, such as drawing numbers from containers, referring to lists, or flipping coins do not provide adequate concealment of allocation and should be avoided.
Blinding
It is also important to understand that allocation concealment is different from blinding in a trial. 17 The former relates to what happens before randomizing patients into the study and seeks to eliminate selection bias, while the latter relates to what happens after randomizing patients into the study and seeks to reduce performance and detection bias. 16 These biases occur when individuals are aware of which intervention participants have received; consequently, the results and the conclusion of the trial will be systematically distorted from the truth. It is possible to conceal the allocation in any RCT, but often not possible to blind certain individuals in surgical trials. Blinding is an important methodological feature of surgical trials and needs to be considered more rigorously. Therefore, trialists should make every effort to incorporate blinding into their trial designs and readers should look for descriptions in the published reports of which individuals were blinded. This rationale strongly suggests that the use of the term "double-blind" should be avoided as it is ambiguous and has different meanings to different individuals.
Several individuals have potential to introduce bias if they have knowledge of which intervention participants have received. In trials of surgical interventions, surgeons can usually not be blinded but participants, other healthcare providers, data collectors, and outcome assessors can often be blinded. Data analysts can always be blinded. Blinding or masking these individuals prevents systematic imbalances in effective concomitant interventions and outcome evaluations. Systematic imbalances are less likely when the outcome of interest is an indisputable end point like death, but it is a most likely occurrence when the outcome measure is subject to measurement bias (ie, quality of life, postoperative pain, joint range of motion, or patient satisfaction). Participants may behave differently if they are aware of the assigned intervention. This might affect their physiological and physical responses to the intervention, withdrawal from the trial, and compliance to concomitant interventions such as physiotherapy and rehabilitation. 17 The blinding of healthcare providers, data collectors, and outcome assessors is important. If they are not blinded, their attitude toward or against an intervention may directly be transferred to participants. For example, their bias toward one intervention could result in differential use and report of concomitant interventions and supplemental care. Blinding outcome assessors protects a trial against the differential assessment of the outcomes.
RCTs of surgical interventions are often more difficult to blind than drug trials, which typically achieve blinding with placebos. 5, 10, 12 Surgical trials often compare interventions that result in different incisions and scars between the treatment groups (eg, laparoscopic vs. open surgery). Creative techniques such as standard wound dressing 10, 18 have made blinding more feasible. For example, in a trial comparing minicholecystectomy to laparoscopic cholecystectomy, a large dressing covering the entire abdomen was used to blind patients, outcome assessors, and healthcare providers. 19 Unfortunately, surgeons rarely incorporate blinding of outcome assessors into surgical trials. In a systematic review of trials in orthopedic trauma, authors concluded that less than 10% of trials actually blinded the outcome assessors. 20 The authors suggested the following 3 techniques of blinding that could have been applied into these trials: (1) using an independent individual unaware of the treatment allocation to assess whether an outcome had occurred or had not occurred, (2) concealing incisions or scars, and (3) digitally altering radiographs to mask the type of implant. Using these 3 simple techniques, trialists in the RCTs examined could have blinded most of outcome assessors.
It is most problematic to blind group allocation from patients and surgeons when comparing a surgical intervention to nonoperative management. The SPORT trial, 21 which compared discectomy to conservative care for patients with disc-related pain and neurologic symptoms, had important pitfalls. The strong preferences of patients and surgeons, lack of blinding, and a subjective primary outcome resulted in high proportion of cross-over from conservative care to surgery, thus preventing a definitive conclusion to be drawn from the trial. Another example is a trial that compared surgery with nonoperative management for uncomplicated varicose veins. 22 Many patients in the nonoperative treatment group withdrew from the study and had surgery.
In these situations, a true placebo arm would have required sham surgery. 12 Although some trials have incorporated sham surgery (such as RCTs in Parkinson disease 23 and knee osteoarthritis 24 ), there is debate about the ethics of such an approach. Some argue that their use is ethically justified if the risks are minimized, informed consent of participants is obtained, and the potential for bias from the placebo effects of surgery are significant and there is no other suitable methodological alternative to the use of a placebo surgery in a trial. 25, 26 Opponents of sham surgery arms raise concerns about their use because of the risks involved in placebo procedures when there is no hope for benefit. 13 To increase the internal validity of an RCT, researchers should blind as many involved individuals as possible and clearly state which individuals are blinded and how the blinding is achieved. When blinding of patients and healthcare providers is not feasible, surgical researchers should ensure that the study groups are, except for the intervention, treated equally (ie, concomitant interventions and follow-up visits). Another useful tip to reduce the detection bias when blinding is not feasible is to have 2 or more individuals independently assess outcomes and resolve any disagreements with consensus. Blinding of the group allocation for outcome assessors and data analysts should similarly be incorporated into non-RCTs and observational studies whenever possible.
Intention-to-Treat Analysis
In many trials, some participants invariably switch from one intervention to the other due to side effects, apparent lack of effectiveness, or simple change in preferences. If researchers analyze participants based on the intervention that they receive or those who adhered to the protocol (known as per protocol or analysis by treatment administered), 27 they risk introducing prognostic differences between groups and lose benefits conferred by randomization.
Application of the intention-to-treat principle provides the least-biased assessment of the efficacy of the intervention. 27, 28 Intention-to-treat analysis maintains prognostic balance in study arms, reduces the influence of nonadherence, loss to follow-ups and withdrawals, and increases the generalizability. 29 Adherence to protocol is not usually an issue in surgical trials comparing surgical interventions when the treatment is a "one time," irreversible process. 30 However, there may be a chance of "conversion" from new intervention to standard procedure for technical reasons, surgeon's limited experiences with the new intervention or due to comorbidities. For example, in a trial comparing the short-term outcomes of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer, the conversion from laparoscopic-assisted surgery to open surgery was 29%. 31 The postoperative complications in these patients were reported to be greater than other patients. 31 The intentionto-treat analysis does not eliminate bias introduced by conversion, loss to follow-ups or withdrawals, but it provides the best estimate of the effect size that can be expected for participants in whom the intervention is attempted (regardless of the need for conversion).
The optimal solution to minimize the conversion from one treatment to another in surgical trials involves a careful development of study protocol. At the design stage, the investigators should carefully review the inclusion and exclusion criteria to ensure that enrolled participants are equally eligible to receive either intervention. As well, investigators should ensure that the participating surgeons have passed the learning curve stage for the novel procedure (unless the investigators are attempting to assess the effect of introducing a new procedure into practice, which will involve a learning curve for all surgeons).
Complete Follow-up
Failure to account for all patients at the end of the study presents another major threat to internal validity. Patients who do not attend follow-up visits are usually different from the ones who do-they may have died, experienced the outcome of interest, or had a satisfactory outcome. Losses to follow-ups are higher when no treatment is required after surgery, especially when a longer follow-up period with no specific treatment is required. The threats to validity are most prominent when there are systematic differences between comparison groups in the loss to follow-ups, or withdrawals from the study (attrition bias). The differential loss to follow-ups is greater when concomitant interventions, ie, rehabilitation or physiotherapy are required for one arm, but not the other.
For example, Michaels et al 22 conducted an RCT to compare surgery with conservative treatment for uncomplicated varicose veins. At 1-year follow-up, there was significant attrition owing to patients failing to attend follow-up visits or withdrawing from the trial (17% surgery arm vs. 35% conservative arm). Further attempts to contact patients revealed that none in the surgical group withdrew owing to dissatisfaction with surgery, while in the conservative group most withdrawals were among patients who decided to undergo surgery. By the third year of the trial, 52% of participants randomized to conservative management had undergone surgical
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RCTs of Surgical Trials treatment. In this situation, patients undergoing surgery in the nonoperative group may be considered crossovers and, therefore, it is a methodological concern or alternately, it may be considered an outcome. Thus, for instance, when comparing surgery with nonoperative surgery, those in the nonoperative surgery group may crossover to surgery because worsening of the symptoms requiring surgery. Therefore, in some trials, crossing over to surgery is not a methodological problem, but really can be considered a failure of the nonoperative treatment. The authors used an intention-to-treat analysis and despite significant loss to follow-up and attrition bias, the trial demonstrated significant benefits for all outcome measures in favor of surgical treatment. However, the validity of the findings should be interpreted with caution due to many losses to follow-up and differences in the number of withdrawals between the study groups. Many authors do not discuss the details of loss to followups. 32 Researchers have more confidence in trials that have followed most or ideally all participants to completion. Some researchers suggest that fewer than 5% losses leads to smaller bias. 28 Note that the amount of loss to follow-up and its effect on the validity of the trial depends on the event rate and magnitude of effect between treatments and varies from study to study. Intention-to-treat analysis cannot eliminate bias introduced from loss to follow-up as the outcome of these patients is unknown. 27 There are different approaches to handle losses to follow-up, such as multivariable modeling of prognostic factors to predict the most likely outcome in those lost to follow-up and analysis of best-case and worst-case scenarios.
27,28 These approaches do not eliminate the bias introduced from loss to follow-ups, and the conclusions drawn from these studies must be interpreted with caution.
Different methods have been suggested to enhance complete follow-up for all participants. 28, 33 Most of these methods should be considered before randomizing patients into the trial such as excluding those patients unlikely to adhere; fully informing patients of both the burden of the study and of the harms and benefits of the intervention; establishing follow-up visits suited to patients' satisfaction; obtaining contact information to prompt patients to return for follow-up; keeping data collection to minimum; and hiring a research person to accomplish all of the above. It is also important to decide what constitutes an appropriate time interval for the assessment of outcomes for surgical interventions under investigation.
Choices and Selection of Outcome Measures
Outcome measures used in assessing the effects of a surgical intervention have significant impact on the applicability of a trial, and may also impact on its validity. Outcome measures should be patient-important, reliable, accurate, and simple to measure. In some surgical fields, interventions are aimed at reducing mortality and morbidity. Some refer to these as objective or hard outcomes because they are relatively easy to measure, and clearly observable by an outcome assessor. Some so-called "hard outcomes" are generic and are associated with many surgical procedures such as postoperative complications (ie, wound infection, postoperative pain, and venous thrombosis). None of these outcome measures is a discrete entity; numerous measures and definitions are suggested. 12 Although such measurements are important, they may not capture the patient's perspective. 34 Not all surgical interventions are aimed at saving lives, but at curing disease or improving presurgical morbidity and quality of lives (QOL). Some refer to these measures as subjective or soft outcomes because they are patient-reported and they cannot be externally observed.
As it turns out, however, the measurement properties (reliability, validity, responsiveness) of measures such as QOL are often as satisfactory as some of the so-called "hard" outcomes. 34 For example, Bidmead et al 35 compared the objective (videocystourethrography) and patient-reported standardized subjective (conditionspecific QOL tool and the King Health Questionnaire) outcomes of colposuspension for stress incontinence in women and concluded that using both measures appears to produce satisfactory results. Subjective or "soft outcome" measures could be disease-, condition-, or system-specific. These outcomes are measured using developed instruments or tools to evaluate the well-being of a patient with a specific-disease (ie, use of Glasgow Coma Score to evaluate the neurologic state of a trauma patient) or conditions of one body region (ie, use of Boston Carpal Tunnel questionnaire for carpal tunnel syndrome). 34 For example, the outcomes of patients with total knee arthroplasty can be evaluated with a system-specific instrument for knee (ie, Western Ontario and McMaster University Osteoarthritis Index-WOMAC) that focuses on the pain, stiffness, and physical condition of knee and/or with a disease-specific instrument (The McMaster Toronto Arthritis-MACTAR) that focuses on the physical disability of rheumatoid arthritis patients population. 36 Symptom and disease-specific instruments typically have a higher sensitivity than generic health-related quality of life questionnaires. 34 The examples of health-related quality of life questionnaires instruments are short form (SF)-36, SF-12, and EuroQoL questionnaires. They comprise physical, mental, and social factors and combined capture the general well-being of a person. These instruments have demonstrated good validity and are commonly used in different areas of research. 34 The functional capacity after surgery is often evaluated by using 6-or 2-minute walk tests in many surgical areas like orthopedic, lung surgery, and cardiac surgery. Brooks et al 37 examined the validity and sensitivity of the 2-minute walk test in cardiac surgery patients and concluded that it is sensitive to change after cardiac surgery with a moderate correlation with measures of physical functioning, but could not identify those with developed postoperative complications. Some outcomes are rare, some are frequent, and some could be measured in everyone. The rare outcomes, like mortality, myocardial infarction, and stroke, require a large number of participants to gather sufficient data in comparison to outcome measures like pain and QOL that could be measured in all participants. 12 To decrease sample size and increase the number of events, the use of composite outcomes has been applied in some areas of surgery, ie, cardiac surgery. 38 The use of composite outcomes requires careful consideration and their use should be justified. Montori et al 39 have listed 3 questions to guide whether the clinical question could be based on the effect of composite outcome measures or component outcome measures: (1) are these outcomes of similar importance to patients; (2) do these outcomes occur with similar frequency; and (3) are the relative risks similar across components of the composite?
Subjective outcomes are most at risk for bias. Most objective outcomes are also subject to observer bias and random error. For example, the interpretation of clinical outcomes such as those obtained through imaging could be affected if the assessor is aware of treatment allocation. In an RCT of cyclophosphamide and plasma exchange versus placebo, the outcome was assessed by both a blinded and an unblinded neurologist. The blinded assessment of outcome showed no superior effect, whereas the unblinded assessment showed an apparent treatment effect. 40 The authors concluded that physician blinding prevented an erroneous conclusion about treatment efficacy. The assessment of outcome measures should be achieved in a blinded fashion or by independent study personnel to avoid bias. 20, 34 The independent assessment of outcomes by 2 or more experts other than operating surgeons is anther way to limit bias when blinding is not possible.
When designing a surgical trial, the choice and selection of outcome measure should be based on what is important to the patient, and how accurately the patient's perception could be cap-tured. This process starts with a clearly stated research question and objectives. 34 If the objectives of the study are not stated clearly, one cannot be sure what outcome measure is appropriate to address the research question. If the choice of outcome measure is not obvious, the investigators should provide an indication of how this outcome measure informs patient problem with which the surgeons are faced. The literature search for the most up-to-date systematic reviews that have evaluated the choices of outcome and available instruments on the topic of interest is often beneficial. When an instrument is used to measure outcomes such as the degree of pain, range of motion of a joint or QOL, one would be much more confident of the results if investigators have used a test that has been proven to be reliable (measures what is intended to measure), valid (measures the proper outcome), and responsive (to changes in a patient's condition), and is measured in a blinded fashion. These instruments should be administered, if possible, before and after intervention to capture the changes in the outcome. These changes should be measured at different time points to capture early, immediate, and late benefits of the intervention. 41 Current guidelines recommend that, for the improvement of patient care, practitioners should assess patient outcomes using condition-specific instruments primarily and functional aspects of the disease or the injury secondarily. 34 The use of utility scales, secondarily, is also recommended to allow cost-effectiveness analysis.
41

Methods to Minimize Random Error
Random error is the same for all groups being compared (when the allocation ratio is 1:1). This general imprecision or inaccuracy creates "noise" in the data and usually results in underestimating the association between intervention and outcome. 42 There are 4 possible explanations for a "nonsignificant" result from a trial: (1) There truly is no important treatment effect; (2) There truly is an important treatment effect but the study was underpowered (small sample size) to detect that effect; (3) The study was powered appropriately but due to chance alone a significant difference was not observed (even in a properly powered study, one will fail to detect a significant difference when there truly was one in 10%-20% of trials); or (4) One or more aspects of the trial was biased in favor of the control group. Because the determination of sample size is critical in assessing the importance of a "nonsignificant" result, authors should always report why they chose the sample size and journal editors should mandate this reporting. 32 Few surgical trials report and justify sample size calculations and insufficient power is one of the major shortcomings of many surgical trials. 32 Random errors can be reduced by increasing the number of observations. 12 The determination of sample size should be made a priori, and special consideration should be given to the elements involved in a sample size calculation. The researchers should consider clinical as well as statistical significance in the calculation of sample size for a trial. Note that these 2 aspects of sample size calculations are different. Statistical significance simply addresses the likelihood that the observed difference in treatment effect between the surgical interventions is, in truth, not zero, but clinical significance addresses the magnitude of the difference in treatment effect between the surgical interventions. Therefore, the decision on the minimal clinically important difference between surgical interventions needs special consideration as it will have a great impact on the trial's results. Declaring a large clinically minimal important difference, when it is, in truth, small or moderate, will most likely cause the trial to produce a "nonsignificant" result.
There are several methods of determining the minimal clinically important difference including (1) Ask experts and patients, (2) Use data from literature or rather perform a systematic review of available evidence, and (3) Conduct a feasibility (pilot) study.
Because the estimated sample size represents the minimum allowable numbers, factors such as anticipated losses to follow-up, subgroup analyses, and complicated designs require a larger sample size and should be accounted for to ensure adequate levels of power throughout the trial. Performing sample size computations is critical in the design of all research studies, including surgical trials. The ingredients necessary for accurate sample size calculation can be found elsewhere, 43 but consulting an epidemiologist or a biostatistician is strongly recommended.
PRACTICAL CHALLENGES Learning Curve for a New Surgical Intervention
The internal validity of surgical trials is often lower than drug trials because the outcomes are dependent on the characteristics of the participating surgeons and settings. Drug trials risk less differential bias in administering an active drug versus placebo to patients; however, surgery is a skilled, multistep process, and this makes the design of RCTs more challenging. There is a learning process for every new surgical technique, even for a fully trained surgeon. It takes training and experience to become expert in a surgical intervention. Surgeons develop their own belief during their training and practice, and tend to primarily use one single approach to treat a specific problem. 44 It is during the learning curve process that errors and adverse events are more likely to occur; therefore, randomizing patients between an expert surgeon and one with restricted expertise can compromise the validity of the trial. 10, 12, 44 In the MRC-CLASICC trial, comparing laparoscopic-assisted versus open surgery in patients with colorectal cancer, the rate of intraoperative conversion from laparoscopic to open surgery fell from 38% in year 1 to 16% in year 6. 31 Failure to control for the learning curve may underestimate the treatment effect of the novel intervention. 33 The potential for differential bias was estimated through a survey of 139 participating surgeons of the SPRINT trial for the comparison of reaming versus not-reaming before the insertion of an intramedullary nail for the treatment of tibial shaft fracture. 45 There were significantly more surgeons with limited recent use of the nonreamed procedure, which is a more technically challenging procedure.
Approaches to minimize the effect of the learning curve include the following: (1) prespecified number of cases in life-time; (2) number of cases in the year preceding the trial; (3) general training in the area; and (4) outcomes consistent with good practical practice. Other options include assessing skills (eg, videotapes, direct observation, quality scores for specimens) as the number of performed surgery may not guarantee expertise or utilizing an expertise-based design. 
Expertise-Based Design
In expertise-based design, patients are randomized to different surgeons, some of whom deliver only the control surgery and some only the experimental surgery. For example, a multicenter RCT was deigned to assess whether an arthroscopic (mini-open) repair compared with open repair provides better QOL for patients with small-or moderate-sized rotator cuff tears. 46 The investigators assigned surgeons to 1 of the 2 designs to minimize the impact of surgeons' expertise on the outcomes. Those with more than 2 years recent experience in both procedures participated in a conventional design RCT (surgeons performed both procedures). Eligible patients were randomized to 1 of the 2 surgical interventions. Surgeons with primary expertise in only one procedure were paired with surgeons with expertise in the alternative procedure from the same site and participated in an expertise-based design. Eligible patients were then randomized to one of the 2 surgeons to receive the intervention
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RCTs of Surgical Trials assigned to that surgeon. This method has routinely been used in areas where interventions are performed by different specialties such as percutaneous transluminal coronary angioplasty versus coronary artery bypass graft (CABG) surgery. 47 The advantage of expertise-based trials is that expert surgeon would perform both interventions and the learning curve of the new procedure will no longer be an issue. One drawback of expertisebased design is that it is preferable for large trials with multiple surgeons, where the surgeons have strong viewpoints in favor of different procedures (ie, laparoscopic vs. open colon surgery). Each participating center should have expert surgeons doing each type of operation. Another drawback of the expertise-based design is that it adds cost, and increases complexity of the randomization, as it requires stratification by surgeon and center. 33 
Standardization of Surgical Procedures
The standardization of surgical procedures is a difficult task. Almost all innovative surgical procedures are introduced in the form of case-series, and adopted into practice without a proper evaluation. There are often concurrent technical modifications to the innovative procedure. 18 The variability of surgeons' skills in multicenter studies cannot be overlooked. The differences in methods, skills, and experiences of operative teams (residents, nurses, etc) in each case introduce further variation. One approach that investigators might consider is conducting a "pragmatic" or "effectiveness" trial that accepts and even encourages this variability.
Pragmatic Trials Versus Explanatory Trials
Explanatory or efficacy trials (usually referred to as RCTs), are designed to measure the efficacy of an intervention-to find out if the treatment exerts a biologic effect in a research setting under ideal and controlled conditions. Such trials are also referred to as "proof of concept." The aim is to establish the potential of the treatment. Pragmatic or effectiveness trials are designed to measure the effectiveness of an intervention-to explore whether an intervention, as administered in routine practice, is effective in routine and everyday practice settings. 48 The aim is to maximize external validity while sustaining acceptable internal validity to ensure that the results meet the needs of the relevant decision-makers; that is, they provide the information that is needed to guide real-world clinical decisions. Box 2 summarizes conventional methodological features of explanatory and pragmatic trials.
An explanatory approach enrolls as homogenous a population as possible to further the scientific knowledge. In pragmatic trials, there are few restrictions to the inclusion criteria to reflect the variation between patients, which is present in routine practice setting. To ensure generalizability, pragmatic trials must, as far as possible, represent the patient population to whom the treatment will be applied. 48 These trials typically need a larger sample size than explanatory trials because the patients are recruited from a wider and more heterogeneous population. 49 In pragmatic trials (like explanatory trials), patients are randomized to receive one intervention or the other. Explanatory trials often use placebo control; whereas, pragmatic trials should compare the new therapy with the standard treatment. This approach is especially applicable for surgical trials since the ethics of using placebo or sham surgery is controversial. The advantage of pragmatic trials for surgical research is that they grant the surgeons freedom to use their own approaches for different patients, but they still must use the randomly assigned intervention as required. They allow surgeons flexibility of surgical practice, but within a defined framework, because no strict specified protocol for the performance of the surgical procedures is required.
Explanatory trials often measure intermediate or surrogate outcomes relating to the understanding the physiological or biologic responses to the treatment, 48 such as changes in joint range of motion after orthopedic surgery. Pragmatic trials include outcome measures that are important to patients' everyday lives such as improvement in QOL or reduction in stroke. Pragmatic trials typically involve longer follow-up periods than explanatory trials. The economic evaluation of 2 interventions fits well within a pragmatic design.
In reality, surgical trials rarely exhibit features consistent exclusively with "explanatory or efficacy" versus "pragmatic or effectiveness" trials. They lie somewhere along the spectrum between these 2 designs. For example, if a pragmatic surgical trial applies a strict specified treatment protocol for the surgical interventions rather than allowing surgeons the freedom to practice their preferred approaches, then it is no longer fully pragmatic trial. Researchers should choose the design features that are appropriate to the current knowledge about the intervention. Ultimately, trials designed to meet the needs of decision-makers will prove of most use to clinicians and their patients. 
BOX 2. Explanatory Trials Versus Pragmatic Trials
RECRUITMENT
The recruitment of a predetermined number of patients in a reasonable time frame is a difficult practical challenge to overcome in surgical trials. This is a major issue particularly in rare and uncommon conditions. For example, in a retrospective chart review comparing laparoscopic Swenson's procedure to Swenson transanal pull-through in children with Hirschsprung disease, 52 patients were accrued at a single institution in 10 years. 14 If this had been designed as a prospective trial, it would have taken the investigators decades to recruit the number of patients needed to study this question properly. One option for increasing patient recruitment is to conduct multicenter studies. A multicenter approach in the study of rare conditions trades rapid recruitment for the potential drawback of increased heterogeneity 30 ; conversely, there are advantages to increased heterogeneity in terms of applicability and generalizability in surgical trials. Conducting multicenter trials, however, does not reduce the challenges and difficulties of patient recruitment into trial's centers. Csimma and Swiontkowski 50 have discussed the challenges of patient recruitment in BESTT multicenter Tibial trial and provided some potential solutions to overcome these difficulties. Other techniques to maximize recruitment rate in surgical trials are discussed elsewhere.
51
SURGEONS' AND PATIENTS' PREFERENCE
Surgeons' and patients' preferences for one form of surgery may significantly decrease the recruitment rate in surgical trials compared with similar trials of medical interventions. Abraham et al 52 concluded that having a preference for one form of surgery by the surgeon or by the patient was the most common reason for not recruiting 45% of all eligible patients into the Australian Laparoscopic Colorectal Cancer Study. Surgeons are more likely to participate in expertise-based trials because they have the choice of performing their preferred treatment 46 and are more likely to participate in pragmatic trials because they have more flexibility in applying the randomly assigned intervention. 53 Pilot studies are important to assess the feasibility of study design, test the intervention, and obtain preliminary data on the effect size. 54, 55 Factors affecting feasibility include recruitment issues, follow-up issues, surgeon or patient preferences for one surgical approach, inadequacy of the investigational site's resources to conduct the study within the given timeframe, and unanticipated design or procedural problems. 55 Conducting surveys before designing the full trial is especially useful to learn about the participating surgeons' willingness, preferences, and experiences and the investigational site's infrastructure and resources. While conducting a pilot study does not guarantee success in the main study, it does increase the likelihood of success. Some large government funding agencies (ie, Canadian Institute of Health Research (CIHR)) "mandate" the conduct of a pilot study to precede a large multicenter trial. Note that a pilot study is not aimed to answer the research question but is a small exploratory study aimed at the generation or refinement of the hypotheses.
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CONCLUSION
RCTs are the best design to evaluate the efficacy of a novel intervention despite limitations and challenges inherent to surgical trials. They play a central role in providing a basis for evidencebased practice and clinical decision-making. Many barriers and issues of surgical trials affecting internal validity can be overcome with proper methodology, and in most cases these issues do not restrict their conduct. Pragmatic trials are useful to assess how effective an intervention is when compared with some standard or accepted treatment. They overcome some specific challenges that can be encountered with RCTs of surgical interventions. Researchers should consider their research question carefully and design a surgical trial that contains features appropriate for the question. In doing so, they must ensure that the trial is valid, feasible, and affordable-a difficult feat, but one well worth the challenge.
GLOSSARY
Bias: is an inaccuracy which is different in size and direction between groups and can create a misleading impression of overall effect (in a positive or negative direction).
Blinding: is defined as the masking of group allocation from one or more individuals involved in an RCT.
Composite outcomes: in which multiple outcomes are combined and the number of patients who experience one or more of those outcomes are captured.
Concealment of allocation: dictates that the individuals responsible for recruiting and allocating participants to interventions and the participants themselves should be unaware of the next assignment in the randomization sequence.
Detection bias: refers to systematic differences in outcome assessment between the study groups.
Differential bias: refers to systematic differences between the groups being compared which biases the outcome measure of the study in unknown ways.
External validity: refers to the degree to which the results of the study can be generalized to the target population.
Intention-to-treat analysis: it analyzes participants in the groups to which they were randomized, irrespective of the intervention they actually received.
Internal validity: refers to the degree to which we can accurately state that the observed difference in outcome between the study groups, apart from sampling error, can be attributed to the effects of the intervention.
Measurement bias: systematic error arising from inaccurate measurement (or classifications) of patients on study variable(s).
Multivariable modeling: to take into account the effect of more than one factor simultaneously.
Observer bias: refers to systematic differences between a true value and one that was observed, due to the variation (error) introduced by the observer who failed to measure or to identify a phenomenon accurately.
Performance bias: refers to systematic differences in the care provided to study participants.
Propensity score analysis: the probability of receiving a given intervention, conditional on the measured covariates.
Randomization: or random allocation is a method that uses the play of chance to assign participants to possible interventions in a trial (ie, using a computer-generated random sequence, a random number table or simply flipping of a coin).
Randomized controlled trial: are quantitative, comparative, and controlled experiments in which investigators study a series of individuals who receive a randomly assigned intervention.
Reliability: refers to the degree of consistency and stability demonstrated when a measurement is repeated under identical conditions. Selection bias: occurs when there are systematic differences in the characteristics of participants who receive the different study interventions.
Validity, measurement: refers to the degree to which a measurement measures what it purports to measure.
